DSGN
Design Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.14
+0.73%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+43.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 11, 2026 | Shapiro David · director | A-Award | 30,000 | $11 |
| Jun 11, 2026 | Berger Heather A. · director | A-Award | 30,000 | $11 |
| Jun 11, 2026 | LAPPE RODNEY W · director | A-Award | 30,000 | $11 |
| Jun 11, 2026 | Schmid John P. · director | A-Award | 30,000 | $11 |
| Jun 11, 2026 | George Simeon · director, 10 percent owner: | A-Award | 30,000 | $11 |
| Jun 11, 2026 | Gover Justin D. · director | A-Award | 30,000 | $11 |
| Jan 5, 2026 | Shah Pratik · director, officer: President, CEO and Chairperson | A-Award | 750,000 | $9.10 |
| Jan 5, 2026 | Storgard Chris · officer: Chief Medical Officer | A-Award | 250,000 | $9.10 |
| Jan 5, 2026 | Jeffries Sean · officer: Chief Operating Officer | A-Award | 375,000 | $9.10 |
| Jan 5, 2026 | Burgess Julie · officer: Chief Accounting Officer | A-Award | 150,000 | $9.10 |
| Jan 5, 2026 | Gover Justin D. · director | A-Award | 45,000 | $9.10 |
| Dec 11, 2025 | Shah Pratik · director, officer: President, CEO and Chairperson | A-Award | 525,000 | $2.48 |
| Sep 10, 2025 | Gover Justin D. · director | A-Award | 30,000 | $6.64 |
| Sep 10, 2025 | Gover Justin D. · director | A-Award | 15,833 | $6.64 |
| Aug 14, 2025 | William Arsani · director | Sale | 345,000 | $5.25 |
| Aug 14, 2025 | William Arsani · director | Sale | 217,627 | $5.25 |
| Jun 12, 2025 | Schmid John P. · director | A-Award | 19,000 | $4.01 |
| Jun 12, 2025 | LAPPE RODNEY W · director | A-Award | 19,000 | $4.01 |
| Jun 12, 2025 | Berger Heather A. · director | A-Award | 19,000 | $4.01 |
| Jun 12, 2025 | William Arsani · director | A-Award | 19,000 | $4.01 |
| Jun 12, 2025 | Prasad Deepa · director | A-Award | 19,000 | $4.01 |
| Jun 12, 2025 | George Simeon · director, 10 percent owner: | A-Award | 19,000 | $4.01 |
| May 23, 2025 | Storgard Chris · officer: Chief Medical Officer | A-Award | 400,000 | $4.71 |
| Jan 6, 2025 | LAPPE RODNEY W · director | A-Award | 25,993 | $6.17 |
| Jan 6, 2025 | Burgess Julie · officer: Chief Accounting Officer | A-Award | 135,000 | $6.17 |
| Jan 6, 2025 | Shah Pratik · director, officer: President, CEO and Chairperson | A-Award | 600,000 | $6.17 |
| Jan 6, 2025 | Jeffries Sean · officer: Chief Operating Officer | A-Award | 260,000 | $6.17 |
| Dec 19, 2024 | Prasad Deepa · director | Sale | 3,806 | $6.27 |
| Aug 12, 2024 | William Arsani · director | Sale | 814,874 | $4.25 |
| Jun 17, 2024 | Prasad Deepa · director | A-Award | 19,000 | $3.82 |
Institutional positioning
13F filings over the trailing two quarters
New 52Increased 117Reduced 63Sold out 16
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | Unchanged | 6,526,476 | Aug 12, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | Unchanged | 6,526,476 | May 14, 2026 |
| Logos Global Management LP | Increased | 3,000,000 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Increased | 2,972,973 | May 15, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Reduced | 2,722,754 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 2,678,430 | Aug 14, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Increased | 2,661,115 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 2,660,024 | Aug 7, 2026 |
| Caption Management, LLC | Increased | 2,618,098 | Aug 14, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 2,585,978 | May 15, 2026 |
| Point72 Asset Management, L.P. | Reduced | 2,366,453 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 2,133,764 | May 13, 2026 |
| Trails Edge Capital Partners, LP | Increased | 2,001,282 | Aug 14, 2026 |
| LOGOS GLOBAL MANAGEMENT LP | Reduced | 1,950,000 | May 15, 2026 |
| Frazier Life Sciences Management, L.P. | New Position | 1,809,854 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 11, 2026